background image

Regeneron Pharmaceuticals Clinical Trials

Find clinical trials for Regeneron Pharmaceuticals. Search for Regeneron Pharmaceuticals clinical trials in different cities and states across the United States.

Filter
Active & Responsive

A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants With Hearing Loss Due to Otoferlin Mutations

for
Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF),
Location: Boston MA, New York NY, Orlando FL, Jacksonville FL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 0 - 17

Code: NCT05788536

Phase1, Phase2, Recruiting
New

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

for
Venous Thromboembolism (VTE)
Location: Hialeah FL, El Paso TX
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07493304

Phase3, Recruiting
New

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

for
Diffuse Large B-cell Lymphoma (DLBCL)
Location: Boston MA, Stony Brook NY, New Brunswick NJ,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06091865

Phase3, Recruiting
New

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

for
Peripheral Artery Disease (PAD)
Location: Amarillo TX
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07318610

Phase3, Recruiting

A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works

for
Paroxysmal Nocturnal Hemoglobinuria
Location: Toronto
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05744921

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

for
Relapsed Refractory Multiple Myeloma (RRMM)
Location: Durham NC
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05730036

Phase3, Recruiting

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)

for
Adverse Pregnancy Outcomes, Atopic Dermatitis
Location: Boston MA
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18 - 49

Code: NCT03936335

Recruiting

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

for
Monoclonal Gammopathy of Undetermined Significance (MGUS),
Location: Boston MA, Stony Brook NY, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06140524

Phase2, Recruiting

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: New York NY, Tampa FL, Columbus OH, Atlanta GA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03761108

Phase1, Phase2, Recruiting

A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

for
Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma,
Location: Boston MA, Hackensack NJ, Buffalo NY, Pittsburgh PA,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06469281

Phase1, Recruiting